Header Logo

Connection

BRANT WANG to Female

Back to Details
This is a "connection" page, showing publications BRANT WANG has written about Female.
BRANT WANG
Connection Strength
0.182
Female
  1. Cytologic Diagnoses of Lung Adenocarcinoma With Concomitant Metastasis From a Different Primary: A Case Series. Diagn Cytopathol. 2025 Jun; 53(6):E102-E107.
    View in: PubMed
    Score: 0.038
  2. Corpora amylacea in pleural effusion. Diagn Cytopathol. 2021 Jun; 49(6):E231-E233.
    View in: PubMed
    Score: 0.028
  3. Cytohistopathologic correlation of ovarian mesonephric-like carcinoma and female adnexal tumor of probable Wolffian origin. Diagn Cytopathol. 2021 Jun; 49(6):E207-E213.
    View in: PubMed
    Score: 0.028
  4. Ultrasound-guided fine-needle aspiration of a rectal submucosal nodule. Diagn Cytopathol. 2020 Feb; 48(2):159-163.
    View in: PubMed
    Score: 0.026
  5. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma. Gynecol Oncol. 2007 Jul; 106(1):201-6.
    View in: PubMed
    Score: 0.011
  6. Aneuploidy Landscape in Precursors of Ovarian Cancer. Clin Cancer Res. 2024 02 01; 30(3):600-615.
    View in: PubMed
    Score: 0.009
  7. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions. Am J Surg Pathol. 2024 Apr 01; 48(4):475-486.
    View in: PubMed
    Score: 0.009
  8. Increased plasma DNA integrity in cancer patients. Cancer Res. 2003 Jul 15; 63(14):3966-8.
    View in: PubMed
    Score: 0.008
  9. Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis. Cancer Res. 2022 12 16; 82(24):4528-4541.
    View in: PubMed
    Score: 0.008
  10. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions. J Pathol. 2019 05; 248(1):41-50.
    View in: PubMed
    Score: 0.006
  11. Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: a clinicopathologic study of 84 patients originally classified as FIGO stage II. Gynecol Oncol. 2010 Nov; 119(2):250-4.
    View in: PubMed
    Score: 0.003
  12. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas. Clin Cancer Res. 2004 Oct 01; 10(19):6432-6.
    View in: PubMed
    Score: 0.002
  13. Molecular genetic analysis of ovarian serous cystadenomas. Lab Invest. 2004 Jun; 84(6):778-84.
    View in: PubMed
    Score: 0.002
  14. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst. 2003 Mar 19; 95(6):484-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.